Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Food Chem Toxicol ; 173: 113626, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36682415

ABSTRACT

This study investigated the phytochemical profile of Drimia numidica leaf methanolic extract, as well as its cyto-genotoxic and cyto/genoprotective potential against mitomycin C (MMC) mediated effects on healthy human lymphocytes. Photosynthetic pigments, trace elements, and secondary metabolites were estimated and/or identified in methanolic extract of mature leaves, and the latter was further used for assessing its in vitro biological effects on MMC-free and/or MMC-treated human lymphocytes (at low, non-toxic concentrations of 0.001 and 0.01% v/v). The results showed that D. numidica leaf methanolic extract, being rich in carotenoids, phenolics, flavonoids, organic acids and bufadienolides, could be protective against MMC mediated cyto/genotoxic potential in healthy human lymphocytes. Biomolecules possessing antioxidant and antitumor potential, such as beta-carotene and lutein among others, chlorogenic acid, caffeic acid and their derivatives, minerals such as Si, as well as apigenin- and luteolin-derived glycosides, either individual or in a mixture, could be beneficial rather than harmful, at least at the extract concentrations tested. Although further in vitro and in vivo studies are still needed for elucidating the beneficial (individual and/or additive/synergistic) role of those compounds, the results of the present study are quite promising, thus encouraging new challenges for the appropriate utilization of D. numidica leaf extract.


Subject(s)
Drimia , Mitomycin , Humans , Mitomycin/toxicity , Drimia/chemistry , Plant Extracts/pharmacology , DNA Damage , Lymphocytes , Plant Leaves
2.
Drug Chem Toxicol ; 45(2): 940-946, 2022 Mar.
Article in English | MEDLINE | ID: mdl-32752893

ABSTRACT

The study was designed to evaluate antigenotoxic effect of methanol Teucrium arduini and Teucrium flavum extracts against mitomycin C (MMC)-induced chromosome and DNA damage in vitro. Cytokinesis-block micronucleus (CBMN) and comet assays were used to investigate effect of plant extracts in different concentrations (125, 250, 500 and 1000 µg/mL) on human peripheral blood lymphocytes (PBLs). The obtained results showed that the all tested concentrations of T. arduini and the highest concentration of T. flavum significantly reduced the MMC-induced micronucleus (MN) frequency in comparison to positive control (only MMC). There were significantly negative correlations between the extracts concentrations and MN frequencies (Pearson, r = -0.905, p = 0.0001 for T. arduini; r = -0.861, p = 0.0001 for T. flavum). The extracts of both plants further lowered the MMC-decreased nuclear division index (NDI) in a dose dependent-manner (Pearson, r = -0.837, p = 0.001 for T. arduini; r = -0.598, p = 0.040 for T. flavum), but significantly only in the highest concentration (1000 µg/mL). Comet assay showed that extracts reduced MMC-increased genetic damage index (GDI), significantly in the concentrations of 500 and 1000 µg/mL, in comparison with positive control. Based on our results, it can be concluded that methanol T. arduini and T. flavum extracts possess protective proapoptotic and antigenotoxic effect which is indication of their medicinal relevance and use in treatment.


Subject(s)
Teucrium , Humans , Lymphocytes , Methanol , Micronucleus Tests , Mitomycin/toxicity , Plant Extracts/pharmacology
3.
Drug Chem Toxicol ; 44(4): 409-417, 2021 Jul.
Article in English | MEDLINE | ID: mdl-30945575

ABSTRACT

Rhus coriaria has been important in the treatment of many diseases in traditional use. In this content, the genotoxic, antigenotoxic, and oxidative stress effects of methanol extract of R. coriaria (RCE) were investigated in this study. Two hundred fifty, 500, or 750 µg/mL concentrations of RCE were not found to have DNA damaging effect on pET22-b(+) plasmid and were unable to induce micronuclei in human lymphocytes (24 or 48 h treatment period). However, it did not inhibit the genotoxic effect of mitomycin-c (0.25 µg/mL). Cytotoxic effects of RCE were investigated using mitotic index (MI) and nuclear division index (NDI). Five hundred, 1000, and 2000 mg/kg concentrations of RCE did not induce chromosome aberrations in rat bone marrow cells for 12 or 24 h treatment period. In addition, 2000 mg/kg concentration of RCE showed an antigenotoxic effect by decreasing to genotoxic effect of 400 mg/kg urethane at 12 and 24 h treatment periods. RCE showed cytotoxic effects by significantly decreasing NDI. Moreover, RCE increased cytotoxic effect of Mitomycin C (MMC). However, RCE did not induce cytotoxicity in rat bone marrow cells. The highest concentration of RCE reduced total oxidant level in 12 h treatment. Interestingly, the lowest total oxidant level was found in rats blood treated with the lowest concentration RCE and urethane together. Thousand and 2000 mg/kg concentrations of RCE decreased total antioxidant levels of rat blood at 24 h treatment period. Our results showed that RCE possess cytotoxic effect in short-term treatments in vitro. However, it does not demonstrate genotoxic or cytotoxic effects in vivo.


Subject(s)
Antioxidants/metabolism , Oxidative Stress/drug effects , Plant Extracts/administration & dosage , Rhus/chemistry , Adult , Animals , Antimutagenic Agents/pharmacology , Bone Marrow Cells/drug effects , Chromosome Aberrations/drug effects , DNA Damage/drug effects , Dose-Response Relationship, Drug , Female , Humans , In Vitro Techniques , Male , Mitomycin/toxicity , Mutagenicity Tests , Plant Extracts/pharmacology , Plant Extracts/toxicity , Rats , Rats, Sprague-Dawley , Young Adult
4.
Drug Chem Toxicol ; 41(3): 368-375, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29447011

ABSTRACT

Glycyrrhiza glabra L. (licorice) is one of the most important medicinal plants, which is widely used throughout the world both in traditional and contemporary medical industries. This study was undertaken to investigate the potential genotoxic activity of G. glabra methanolic root extract, and its possible antigenotoxic properties against mitomycin C (MMC)-induced DNA damage in in vitro chromosome aberrations (CAs) and cytokinesis-block micronucleus (CBMN) assays in human peripheral blood lymphocytes (PBLs). Lymphocytes were treated with 25, 50, and 100 µg/ml G. glabra methanolic root extract alone as well as in combination with MMC (0.1 µg/ml) for 24 and 48 h treatment periods. It was found that there were no statistically significant differences between the negative control and the groups treated with all concentrations of G. glabra root extract of alone (p > 0.05), demonstrating the absence of genotoxic effects at both 24 and 48 h treatment periods. Besides, the co-treatment of G. glabra methanolic root extract and MMC significantly decreased the percentage of structural CAs and MN formation when compared with the culture treated with MMC alone (p < 0.001). In addition, the negative interaction factor (IF) values obtained for all combinations represent an antagonistic effect of G. glabra versus MMC. We can state that this extract acts as an antagonist and markedly decreased MMC-induced cytogenotoxicity. In conclusion, the present results demonstrate that in the tested experimental conditions, G. glabra methanolic root extract is not genotoxic in cultured human PBLs and has also antigenotoxic activity against MMC, which is widely used in chemotherapy against cancer.


Subject(s)
Glycyrrhiza , Lymphocytes/drug effects , Plant Extracts/pharmacology , Adult , Chromosome Aberrations , Female , Humans , Male , Micronucleus Tests , Mitomycin/toxicity , Plant Roots
5.
Drug Chem Toxicol ; 41(1): 82-88, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28635332

ABSTRACT

Herbal products contain a variety of compounds which may be useful in protecting against cellular damage caused by mutagens. Orthosiphon stamineus (O.s) also known as Cat whiskers. The herb has been shown anti-oxidative properties and can modulate key cellular proteins that have cytoprotective effect. The study aimed to evaluate the effects of different doses (250, 500 and 1000 mg kg-1) of 50% ethanol extract of O.s (Et. O.s) on micro-nucleated polychromatic erythrocytes (MNPCE), Polychromatic to normachromatic erythrocytes ratio (PCE/NCE), Mitotic index (MI), and Chromosomal aberration (CA) in Bab/c mice. Moreover, these parameters were used to evaluate the anti-genotoxic and clastogenic potencies of (Et. O.s) against mitomycin c (MMC) that interact with biological molecules and induce genotoxic and clastogenic disorders in non-tumor cells. MMC (4 mg kg-1) was injected intraperitoneally (i.p.) to the mice before and after treatment with three different doses of (Et. O.s). The results indicated that the extract at different doses did not show significant (p ≥ 0.05) differences in (MNPCE), (PCE/NCE) ratios, and (CA) values. The higher doses sowed high (MI) values compared with untreated control group. MMC showed significant increase (p ≤ 0.001) in (MNPCE), (CA) and reduce (PCE/NCE) and (MI) values compared with untreated control group. Treatment with (Et. O.s) at different doses before and after MMC injection showed to modulate MNPCE, PCE/NCE ratios, CA and MI values in mice bone marrow cells suggesting genoprotective potential of this plant extract.


Subject(s)
Antimutagenic Agents/pharmacology , Bone Marrow Cells/drug effects , Erythrocytes/drug effects , Ethanol/chemistry , Femur/drug effects , Micronuclei, Chromosome-Defective/chemically induced , Mitomycin/toxicity , Mutagens/toxicity , Orthosiphon , Plant Extracts/pharmacology , Solvents/chemistry , Animals , Antimutagenic Agents/isolation & purification , Bone Marrow Cells/pathology , Dose-Response Relationship, Drug , Erythrocytes/pathology , Femur/pathology , Male , Mice, Inbred BALB C , Micronucleus Tests , Orthosiphon/chemistry , Phytotherapy , Plant Extracts/isolation & purification , Plant Leaves , Plants, Medicinal , Risk Assessment
6.
J Ethnopharmacol ; 210: 179-191, 2018 Jan 10.
Article in English | MEDLINE | ID: mdl-28866044

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Sijunzi decoction (SJZD) is a well known traditional Chinese prescription used for the treatment of gastrointestinal disorders and immunity enhancement. It has been found to indeed improve life quality of chemotherapy patients and extensive used in clinical conbined with chemotherapeutics for the treatment of cancer. AIM OF THE STUDY: The aim of this study was to investigate the preventive effect of the immunotoxicity of SJZD on mitomycin C (MMC) and the metabolic mechanism of action. MATERIALS AND METHODS: NMR and MS-based metabolomics approaches were combined for monitoring MMC-induced immunotoxicity and the protective effect of SJZD. Body weight change and mortality, histopathological observations and relative viscera weight determinations of spleen and thymus, sternum micronucleus assay and hematological analysis were used to confirm the immunotoxicity and attenuation effects. An OPLS-DA approach was used to screen potential biomarkers of immunotoxicity and the MetaboAnalyst and KEGG PATHWAY Database were used to investigate the metabolic pathways. RESULTS: 8 biomarkers in plasma samples, 19 in urine samples and 10 in spleen samples were identified as being primarily involved in amino acid metabolism, carbohydrate metabolism and lipid metabolism. The most critical pathway was alanine, aspartate and glutamate metabolism. CONCLUSIONS: The variations in biomarkers revealed the preventive effect of the immunotoxicity of SJZD on MMC and significant for speculating the possible metabolic mechanism.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Drugs, Chinese Herbal/pharmacology , Immune System/drug effects , Mitomycin/toxicity , Animals , Biomarkers/metabolism , Male , Mass Spectrometry , Metabolomics/methods , Proton Magnetic Resonance Spectroscopy , Rats , Rats, Sprague-Dawley
7.
Biomed Pharmacother ; 95: 252-263, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28846983

ABSTRACT

Development of excellent curative therapy for most of the malignancies has resulted in a growing population of cancer survivors who are at increased risk for a variety of health problems including infertility. Therefore, fertility preservation has become an important issue during cancer treatment in recent years. Combination therapy with natural agents such as vitamins, antioxidants, dietary supplements, and plant products are considered as an attractive option to mitigate normal tissue toxicity imparted by chemotherapy. The aim of the present study was to explore the beneficial effect of hydroethanolic extract of Indian propolis (HEIP) on mitigating mitomycin C (MMC)-induced testicular damage and its mechanism of action. Healthy adult male mice were injected intraperitoneally with saline, MMC, HEIP and HEIP followed by MMC after 1h. The animals were dissected at 35days after various treatments to analyze testicular function. MMC administration resulted in significant reduction in testicular function in a dose-dependent manner at 35days after treatment which significantly improved by HEIP pre-treatment. At 24h after treatment, MMC induced significant increase in oxidative stress, γ-H2AX foci and expression of RAD51 and KU80 in testicular cells. Prior treatment with HEIP decreased the oxidative stress, reduced DNA damage and restored the testicular testosterone and inhibin B level. In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy.


Subject(s)
Antioxidants/metabolism , DNA Damage/drug effects , Mitomycin/toxicity , Propolis/pharmacology , Testis/drug effects , Testis/metabolism , Animals , DNA Damage/physiology , India , Male , Mice , Propolis/isolation & purification , Spermatozoa/drug effects , Spermatozoa/metabolism , Spermatozoa/pathology , Testis/pathology
8.
PLoS One ; 10(6): e0130498, 2015.
Article in English | MEDLINE | ID: mdl-26110900

ABSTRACT

Chios mastic oil (CMO), the essential oil derived from Pistacia lentiscus (L.) var. chia (Duham), has generated considerable interest because of its antimicrobial, anticancer, antioxidant and other beneficial properties. In the present study, the potential genotoxic activity of CMO as well as its antigenotoxic properties against the mutagenic agent mitomycin-C (MMC) were evaluated by employing the in vitro Cytokinesis Block MicroNucleus (CBMN) assay and the in vivo Somatic Mutation And Recombination Test (SMART). In the in vitro experiments, lymphocytes were treated with 0.01, 0.05 and 0.10% (v/v) of CMO with or without 0.05 µg/ml MMC, while in the in vivo assay Drosophila larvae were fed with 0.05, 0.10, 0.50 and 1.00% (v/v) of CMO with or without 2.50 µg/ml MMC. CMO did not significantly increase the frequency of micronuclei (MN) or total wing spots, indicating lack of mutagenic or recombinogenic activity. However, the in vitro analysis suggested cytotoxic activity of CMO. The simultaneous administration of MMC with CMO did not alter considerably the frequencies of MMC-induced MN and wing spots showing that CMO doesn't exert antigenotoxic or antirecombinogenic action. Therefore, CMO could be considered as a safe product in terms of genotoxic potential. Even though it could not afford any protection against DNA damage, at least under our experimental conditions, its cytotoxic potential could be of interest.


Subject(s)
DNA Damage/drug effects , Lymphocytes/drug effects , Pistacia/chemistry , Animals , Humans , Micronucleus Tests , Mitomycin/toxicity , Mutagenicity Tests , Plant Oils/administration & dosage , Plant Oils/chemistry , Protective Agents , Wings, Animal/drug effects
9.
J Nat Med ; 69(3): 267-77, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25666712

ABSTRACT

DIG, a liquid herbal preparation made from a mixture of diluted mother tinctures of Berberis vulgaris, Taraxacum officinale and Arctium lappa, was assessed for its antimutagenic properties against mitomycin C. The micronucleus assay on Chinese hamster ovary (CHO)-K1 cells was used to evaluate the in vitro anticlastogenic activity of DIG compared to those of separately diluted mother tinctures. The micronucleus assay was performed on mouse erythrocytes and the comet assay was performed on mouse liver, kidney, lung, brain and testicles to assess the protective effects of DIG (0.2 and 2 % at libitum) against an intraperitoneal injection of mitomycin C (1 mg Kg(-1)) in mice. DIG exerted a powerful anticlastogenic activity, under both pretreatment and simultaneous treatment conditions as assessed by the micronucleus assay in CHO-K1 cells. Its protective activity was greater than that observed for each mother tincture. DIG reduced micronuclei levels in mouse erythrocytes and suppressed >80 % of DNA strand breaks in the liver, kidney, lung, brain and testicles of mice exposed to mitomycin C.


Subject(s)
Antimutagenic Agents/pharmacology , Mitomycin/toxicity , Mutagens/toxicity , Plant Extracts/pharmacology , Animals , Arctium/chemistry , Berberis/chemistry , CHO Cells , Comet Assay , Cricetinae , Cricetulus , DNA Damage/drug effects , Dose-Response Relationship, Drug , Erythrocytes/drug effects , Male , Mice , Micronucleus Tests , Taraxacum/chemistry
10.
Regul Toxicol Pharmacol ; 68(2): 240-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24389363

ABSTRACT

The safety of enzyme-treated asparagus extract (ETAS) developed as a novel anti-stress functional material was assessed in acute and subchronic studies and genotoxicity assays. In the acute oral dose toxicity study, all rats survived during the test period and ETAS did not influence clinical appearance, body weight gain and necropsy findings at a dosage of 2000mg/kg body weight. Thus, the 50% lethal dose (LD50) of ETAS was determined to be greater than 2000mg/kg. The 90-day subchronic study (500, 1000 and 2000mg/kg body weight, delivered by gavage) in rats reported no significant adverse effects in food consumption, body weight, mortality, urinalysis, hematology, biochemistry, necropsy, organ weight and histopathology. In the micronucleus test of mice, the incidence of micronuclei in ETAS-administered groups (500, 1000 and 2000mg/kg/day, injected twice) was equivalent to that of the negative control group, while the positive control group receiving mitomycin C showed a high incidence. The potential of ETAS to induce gene mutation was tested using four Salmonella typhimurium strains and Escherichia coli WP2uvrA. The test sample was not mutagenic to the test strains. These results support the safety of ETAS as food and dietary supplement.


Subject(s)
Asparagus Plant/chemistry , Plant Extracts/toxicity , Administration, Oral , Animals , Dose-Response Relationship, Drug , Escherichia coli/genetics , Female , Male , Mice , Mice, Inbred ICR , Micronucleus Tests , Mitomycin/toxicity , Mutagenicity Tests/methods , Plant Extracts/administration & dosage , Rats , Rats, Sprague-Dawley , Salmonella typhimurium/genetics , Toxicity Tests, Acute/methods , Toxicity Tests, Subchronic/methods
11.
An Acad Bras Cienc ; 85(3): 955-64, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24068085

ABSTRACT

Ethnobotanical surveys of Cerrado native plants show that leaves of Celtis iguanaea (Jacq.) Sargent (Cannabaceae), popularly known in Brazil as "esporão de galo", are used in folk medicine for body pain, asthma, cramps, poor digestion, urinary infection, kidney dysfunctions, as well as a stimulant and diuretic. This work aimed at evaluating possible C. iguanaea aqueous leaf extract (CALE) cytotoxicity, genotoxicity, and antigenotoxicity using the mouse bone marrow micronucleous test. To assess CALE genotoxicity, Swiss mice were orally treated with three different extract concentrations (100, 300, and 500 mgkg-1). To evaluate its antigenotoxicity, the same doses were used simultaneously with a single i.p. dose of mitomycin C (MMC, 4mg.kg-1). The frequencies of micronucleated polychromatic erythrocytes (MNPCE) were evaluated 24 h and 48 h after administration except for the negative control (24 h). Genotoxicity was evaluated using the frequency of micronucleated polychromatic erythrocytes (MNPCE), whereas cytotoxicity was assessed by the polychromatic and normochromatic erythrocytes ratio (PCE/NCE). The results showed that CALE did not exhibit a significant reduction in the PCE/NCE ratio, neither a considerable increase in the frequency of MNPCE. Nonetheless, CALE reduced bone marrow toxicity (increased PCE/NCE ratio) and decreased the micronuclei frequency induced by MMC. We can conclude that CALE presented no cytotoxic and genotoxic effects, but showed antigenotoxic and anticytotoxic actions under the experimental conditions applied in this study.


Subject(s)
Antimutagenic Agents/pharmacology , Mutagens/toxicity , Plant Extracts/pharmacology , Ulmaceae/chemistry , Animals , Bone Marrow Cells/drug effects , DNA Damage/drug effects , Dose-Response Relationship, Drug , Male , Mice , Micronucleus Tests , Mitomycin/antagonists & inhibitors , Mitomycin/toxicity , Plant Extracts/toxicity , Toxicity Tests, Acute
12.
Food Chem Toxicol ; 62: 521-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24071477

ABSTRACT

Terminalia actinophylla has been used for anti-diarrheic and haemostatic purposes in Brazil. The fly spot data obtained after exposure of marker-heterozygous Drosophila melanogaster larvae to T. actinophylla ethanolic extract (TAE) in the standard (ST) and high bioactivation (HB) crosses revealed that TAE did not induce any statistically significant increment in any spot categories. Differences between the two crosses are related to cytochrome P450 (CYPs) levels. In this sense, our data pointed out the absence of TAE-direct and indirect mutagenic and recombinagenic action in the Somatic Mutation and Recombination Test (SMART). When the anti-genotoxicity of TAE was analyzed, neither mitomycin C (MMC) nor ethylmethanesulfonate (EMS) genotoxicity was modified by the post-exposure to TAE, which suggests that TAE has no effect on the mechanisms involved in the processing of the lesions induced by both genotoxins. In the mwh/flr(3) genotype, co-treatment with TAE may lead to a significant protection against the genotoxicity of MMC and a weak but significant effect in the toxic genetic action of EMS. The overall findings suggested that the favorable modulations by TAE could be, at least in part, due to its antioxidative potential.


Subject(s)
Antimutagenic Agents/pharmacology , Drosophila melanogaster/drug effects , Mutagenicity Tests/methods , Plant Extracts/pharmacology , Terminalia/chemistry , Animals , Brazil , Crosses, Genetic , Cytochrome P-450 Enzyme System/genetics , Drosophila melanogaster/genetics , Ethanol , Female , Larva/drug effects , Larva/genetics , Male , Mitomycin/toxicity , Wings, Animal/drug effects
13.
PLoS One ; 8(7): e69494, 2013.
Article in English | MEDLINE | ID: mdl-23936030

ABSTRACT

Chios mastic gum, a plant-derived product obtained by the Mediterranean bush Pistacia lentiscus (L.) var. chia (Duham), has generated considerable interest because of its antimicrobial, anticancer, antioxidant and other beneficial properties. Its aqueous extract, called Chios mastic water (CMW), contains the authentic mastic scent and all the water soluble components of mastic. In the present study, the potential genotoxic activity of CMW, as well as its antigenotoxic properties against the mutagenic agent mitomycin-C (MMC), was evaluated by employing the in vitro Cytokinesis Block MicroNucleus (CBMN) assay and the in vivo Somatic Mutation And Recombination Test (SMART). In the former assay, lymphocytes were treated with 1, 2 and 5% (v/v) of CMW with or without MMC at concentrations 0.05 and 0.50 µg/ml. No significant micronucleus induction was observed by CMW, while co-treatment with MMC led to a decrease of the MMC-induced micronuclei, which ranged between 22.8 and 44.7%. For SMART, larvae were treated with 50 and 100% (v/v) CMW with or without MMC at concentrations 1.00, 2.50 and 5.00 µg/ml. It was shown that CMW alone did not modify the spontaneous frequencies of spots indicating lack of genotoxic activity. Τhe simultaneous administration of MMC with 100% CMW led to considerable alterations of the frequencies of MMC-induced wing spots with the total mutant clones showing reduction between 53.5 and 74.4%. Our data clearly show a protective role of CMW against the MMC-induced genotoxicity and further research on the beneficial properties of this product is suggested.


Subject(s)
Drosophila melanogaster/drug effects , Lymphocytes/drug effects , Mutagens/toxicity , Plant Extracts/pharmacology , Wings, Animal/drug effects , Animals , Humans , Micronucleus Tests , Mitomycin/toxicity , Mutation/genetics , Recombination, Genetic/genetics
14.
An Acad Bras Cienc ; 85(2): 553-60, 2013.
Article in English | MEDLINE | ID: mdl-23828357

ABSTRACT

Solanum paniculatum L. is a plant species widespread throughout tropical America, especially in the Brazilian Cerrado region. It is used in Brazil for culinary purposes and in folk medicine to treat liver and gastric dysfunctions, as well as hangovers. Previous studies with S. paniculatum ethanolic leaf extract or ethanolic fruit extract demonstrated that they have no genotoxic activity neither in mice nor in bacterial strains, although their cytotoxicity and antigenotoxicity were demonstrated in higher doses. In order to assess the possible compounds responsible for the activities observed, we fractionated the ethanolic fruit extract of S. paniculatum, characterized by 1H and 13C NMR spectra, and evaluated two fractions containing steroidal alkaloids against mitomycin C (MMC) using the mouse bone marrow micronucleus test. Swiss mice were orally treated with different concentrations (25, 50, or 100 mg.kg-1) of each fraction simultaneously with a single intraperitonial dose of MMC (4 mg.kg-1). Antigenotoxicity was evaluated by using the frequency of micronucleated polychromatic erythrocytes (MNPCE), whereas anticytotoxicity was assessed by the polychromatic and normochromatic erythrocytes ratio (PCE/NCE). Our results demonstrated that steroidal alkaloids isolated from S. paniculatum strongly protected cells against MMC aneugenic and/or clastogenic activities as well as modulated MMC cytotoxic action.


Subject(s)
Antimutagenic Agents/pharmacology , Bone Marrow Cells/drug effects , Erythrocytes/drug effects , Fruit/chemistry , Mitomycin/toxicity , Solanum/chemistry , Animals , Antimutagenic Agents/isolation & purification , Bone Marrow Cells/pathology , Erythrocytes/cytology , Magnetic Resonance Spectroscopy , Male , Mice , Micronucleus Tests
15.
Mutat Res ; 753(1): 48-53, 2013 Apr 30.
Article in English | MEDLINE | ID: mdl-23376209

ABSTRACT

Mitomycin C (MMC) is one of the most effective chemotherapeutic agents. However, during clinical use several side effects may occur. Recombinant human erythropoietin (rhEPO), a glycoprotein that regulates haematopoiesis, has been shown to exert an important cyto-protective effect in many tissues. The aim of this study was to explore whether rhEPO protects against MMC-induced genotoxicity in rat bone-marrow cells. Adult male Wistar rats were divided into six groups of 18 animals each: a control group, a 'rhEPO alone' group, an 'MMC alone' group and three 'rhEPO+MMC' groups (pre-, co- and post-treatment conditions). Our results show that MMC induced a noticeable genotoxic effect in rat bone-marrow cells. rhEPO reduced the effects of MMC significantly in every type of experiment conducted, such as the frequency of micronuclei, the percentage of chromosome aberrations and the level of DNA damage measured with the comet assay. The protective effect of rhEPO was more efficient when it was given 24h prior to MMC treatment.


Subject(s)
Alkylating Agents/antagonists & inhibitors , Antimutagenic Agents/therapeutic use , Chromosome Aberrations/drug effects , DNA Fragmentation/drug effects , Erythropoietin/therapeutic use , Micronuclei, Chromosome-Defective/drug effects , Mitomycin/antagonists & inhibitors , Alkylating Agents/toxicity , Animals , Antimutagenic Agents/administration & dosage , Antimutagenic Agents/pharmacology , Bone Marrow Cells/drug effects , Bone Marrow Cells/ultrastructure , Drug Administration Schedule , Drug Evaluation, Preclinical , Epoetin Alfa , Erythropoietin/administration & dosage , Erythropoietin/pharmacology , Male , Micronucleus Tests , Mitomycin/toxicity , Random Allocation , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Recombinant Proteins/therapeutic use
16.
Toxicol Ind Health ; 29(1): 23-37, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22323477

ABSTRACT

4-Thujanol (sabinene hydrate), a bicyclic monoterpene alcohol, is found in the essential oils of many aromatic and medicinal plants and is widely used as a fragrance and flavouring agent in many different products. The aim of this study was to evaluate the protective effects of 4-thujanol against the genotoxic effects induced by mitomycin C (MMC) and cyclophosphamide (CP) in human lymphocytes, using the chromosome aberrations, sister chromatid exchanges, and micronucleus tests, in the absence and in the presence of S9 mix, respectively. The cells were treated with 0.25 µg/mL MMC and 28 µg/mL CP as alone and cotreated with 13 + 0.25, 26 + 0.25, and 52 + 0.25 µg/mL 4-thujanol + MMC and with 13 + 28, 26 + 28, and 52 + 28 µg/mL 4-thujanol + CP as a mixture. The present study showed that 4-thujanol was unable to reduce the genetic damage induced by MMC, in the absence of S9 mix. On the other hand, probably the metabolites of 4-thujanol act as an antagonist and markedly antagonize CP-induced genotoxicity, in the presence of S9 mix. In general, 4-thujanol + MMC and 4-thujanol + CP decreased the mitotic index, proliferation index and nuclear division index to the same extent or more than those of individual exposure of MMC or CP. In conclusion, 4-thujanol significantly reduced (p < 0.001) the genotoxic damage induced by CP but not MMC when compared with the respective positive control alone. We can suggest that 4-thujanol may improve the chemopreventive effects and may also reduce the harmful side effects of CP, which is widely used in chemotherapy against cancer, without reducing its antiproliferative activities.


Subject(s)
Antimutagenic Agents/pharmacology , Cyclophosphamide/toxicity , Leukocytes, Mononuclear/drug effects , Mitomycin/toxicity , Monoterpenes/pharmacology , Mutagens/toxicity , Antimutagenic Agents/metabolism , Bicyclic Monoterpenes , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Chromosome Aberrations/chemically induced , Cyclophosphamide/metabolism , DNA/drug effects , DNA Damage/drug effects , Dose-Response Relationship, Drug , Female , Humans , Leukocytes, Mononuclear/pathology , Male , Micronuclei, Chromosome-Defective/drug effects , Micronucleus Tests , Mitomycin/metabolism , Monoterpenes/metabolism , Mutagens/metabolism , Ribosomal Protein S9 , Ribosomal Proteins/metabolism , Young Adult
17.
Mutat Res ; 744(2): 117-24, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22405976

ABSTRACT

Cancer chemoprevention with low-dose combinations of bioactive phytochemicals instead of single agents has been suggested to induce less toxicity and improve efficacy. In this study, we selected four plant food-based phytochemicals, viz. chlorogenic acid (CLA), pelargonidin (PEL), resveratrol (RES) and epigallocatechin gallate (EGCG) to evaluate the in vitro chemoprevention of genotoxic damage in HL-60 cells. These agents were tested either individually or as a combination at two concentrations (with a 10-fold difference) against the genotoxins mitomycin C (MMC), diepoxybutane (DEB) and patulin (PAT). Our preliminary ferric reducing antioxidant power (FRAP) assay demonstrated additive effects when PEL, CLA, RES and EGCG were combined. Results of the cytokinesis-block micronucleus test showed significant protection against genotoxic damage induced by PAT, DEB and MMC when CLA, PEL, RES and EGCG were tested individually. This protective effect of the phytochemicals was not concentration-related. Both low- and high-concentration combinations of CLA, PEL, RES and EGCG showed significant reducing effects on the frequencies of micronuclei induced by PAT, DEB and MMC. However, the micronucleus test did not provide indications of additive or synergistic effects with this combination of phytochemicals. In conclusion, the chemo-preventive effects of PEL, CLA, RES and EGCG against genotoxic damage induced by MMC, DEB and PAT are indicative of a 'saturation effect' when higher concentrations and combinations of these phytochemicals are used.


Subject(s)
Antimutagenic Agents/administration & dosage , DNA Damage/drug effects , Plants/chemistry , Anthocyanins/administration & dosage , Antioxidants/administration & dosage , Catechin/administration & dosage , Catechin/analogs & derivatives , Chlorogenic Acid/administration & dosage , Diet , HL-60 Cells , Humans , Micronucleus Tests , Mitomycin/toxicity , Phytotherapy , Reactive Oxygen Species , Resveratrol , Stilbenes/administration & dosage
18.
J Med Food ; 13(6): 1409-14, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21091254

ABSTRACT

Solanum lycocarpum A. St. Hill. (Family Solanaceae), popularly known in Brazil as lobeira, is a common weed in the Brazilian Cerrado vegetation. The fruits of this species have been used in Brazil for culinary purposes and in folk medicine as a sedative, diuretic, antiepileptic, antispasmodic, hypoglycemic, and hypocholesterolemic agent as well as in the control of obesity. Due to the spreading use of this plant as a therapeutic resource and food, the present study aimed to evaluate the genotoxic, antigenotoxic, and cytotoxic effects of S. lycocarpum ethanolic fruit extract using the mouse bone marrow micronucleus test. Both genotoxicity and antigenotoxicity of this ethanolic fruit extract were evaluated by using the frequency of micronucleated polychromatic erythrocytes, whereas cytotoxicity was assessed by the polychromatic and normochromatic erythrocytes ratio. Our results indicated that although S. lycocarpum ethanolic fruit extract did not exhibit genotoxic effect in mice bone marrow, both cytotoxic and antigenotoxic actions were evidenced at all tested doses.


Subject(s)
Antimutagenic Agents/pharmacology , Cytotoxins/toxicity , Fruit/chemistry , Mutagens/toxicity , Plant Extracts/pharmacology , Plant Extracts/toxicity , Solanum/chemistry , Algorithms , Animals , Animals, Outbred Strains , Antimutagenic Agents/toxicity , Bone Marrow Cells/drug effects , Brazil , Cytotoxins/pharmacology , Dose-Response Relationship, Drug , Male , Medicine, Traditional/adverse effects , Mice , Micronucleus Tests , Mitomycin/antagonists & inhibitors , Mitomycin/toxicity , Mutagens/pharmacology , Random Allocation , Toxicity Tests, Acute
19.
J Med Food ; 13(6): 1424-30, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20950193

ABSTRACT

Solanum paniculatum L. is a plant species widespread throughout tropical America, especially in the Brazilian Savanna region. It is used in Brazil for culinary purposes and in folk medicine to treat liver and gastric dysfunctions, as well as hangovers. Previous studies with S. paniculatum ethanolic leaf extract (ELE) or ethanolic fruit extract (EFE) demonstrated that they have no genotoxic activity meant either in the micronucleus test in mice or in the phage induction SOS Inductest in bacterial strains; however, cytotoxicity was demonstrated in both tests. Because of the spread use of this plant as a therapeutic resource and food, the present study aimed at evaluating the modulator effects of S. paniculatum ELE or EFE against mitomycin C (MMC) using the mouse bone marrow micronucleus test. This short-term test was used to detect the acute effects of responsive erythropoiesis after 24- and 48-hour exposure periods. Swiss-Webster mice were orally treated with three different concentrations (100, 200, or 300 mg/kg) of ELE or EFE simultaneously with a single dose of MMC (4 mg/kg i.p.). Antigenotoxicity was evaluated using the frequency of micronucleated polychromatic erythrocytes (MNPCEs), whereas anticytotoxicity was assessed by the polychromatic/normochromatic erythrocyte ratio. Our results demonstrated that neither the ELE nor EFE of S. paniculatum protected cells against the cytotoxic action of MMC. Nevertheless, the present study showed the antimutagenic effect of ELE after a 24-hour treatment (reduction in the frequencies of MNPCEs after a 48-hour treatment with ELE can be due to toxicity) and no antimutagenic action of the EFE treatment against the aneugenic and/or clastogenic activities of MMC.


Subject(s)
Antimutagenic Agents/pharmacology , Fruit/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Solanum/chemistry , Algorithms , Animals , Animals, Outbred Strains , Antimutagenic Agents/isolation & purification , Antioxidants/isolation & purification , Antioxidants/pharmacology , Bone Marrow Cells/drug effects , Brazil , Dose-Response Relationship, Drug , Male , Medicine, Traditional/adverse effects , Mice , Micronucleus Tests , Mitomycin/antagonists & inhibitors , Mitomycin/toxicity , Mutagens/toxicity , Plant Extracts/isolation & purification , Random Allocation , Toxicity Tests, Acute
20.
Toxicol In Vitro ; 24(3): 707-12, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20123012

ABSTRACT

The chromosomal aberrations (CA) assay and micronucleus (MN) test were employed to investigate the effect in vitro of zerumbone (ZER) on human chromosomes. ZER is a sesquiterpene compound isolated from the rhizomes of wild ginger, Zingiber zerumbet Smith. The rhizomes of the plant are employed as a traditional medicine for some ailments and as condiments. ZER has been shown to have anti-cancer and apoptosis-inducing properties against various human tumour cells. It has also been shown to be active in vivo against a number of induced malignancies. Studies on ZER genotoxicity in cultured human peripheral blood lymphocytes (PBL) have not been reported so far. Therefore, the present study was undertaken to investigate the ability of ZER to induce chromosomal aberrations and micronuclei formation in human lymphocytes in vitro. Human blood samples were obtained from four healthy, non-smoking males aged 25-35years. Cultures were exposed to the drug for 48h at four final concentrations: 10, 20, 40 and 80 microM. Mitomycin C (MMC) was used as a positive control. The results of chromosomal aberrations assay showed that ZER was not clastogenic, when compared to untreated control, meanwhile MN test results showed a dose-dependent increase in MN formation. The overall clastogenic effect of ZER on human PBL was statistically not significant. In conclusion, ZER is a cytotoxic but not a clastogenic substance in human PBL.


Subject(s)
Lymphocytes/drug effects , Mutagens , Sesquiterpenes/toxicity , Adult , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Chromosome Aberrations/drug effects , Cytochalasin B/antagonists & inhibitors , Cytochalasin B/toxicity , Zingiber officinale/chemistry , Humans , Male , Micronucleus Tests , Mitomycin/toxicity , Mitotic Index , Mutagenicity Tests , Nucleic Acid Synthesis Inhibitors/toxicity , Plant Roots/chemistry , Sesquiterpenes/isolation & purification , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL